Related Experiment Video
Updated: Jun 24, 2026

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
Drug discovery in psychiatric illness: mining for gold
1gelmer@mprc.umaryland.edu
Discovering effective psychiatric treatments is challenging. This study introduces Pattern Array, an in vivo data mining approach using whole-animal responses to identify novel drug candidates for central nervous system disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Systems Biology
Background:
- Psychiatric drug discovery faces challenges in identifying treatments for full recovery.
- A systems-based approach to in vivo pharmacology can transform psychiatric drug development.
- Data mining strategies are crucial for advancing systems biology efforts.
Purpose of the Study:
- To present a novel in vivo data mining approach for psychiatric drug discovery.
- To utilize whole-animal systems responses for identifying predictive psychopharmacological attributes.
- To establish a framework for screening novel chemical entities based on their net central nervous system effect.
Main Methods:
- The Pattern Array approach was developed for in vivo data mining.
- Whole-animal responses were used to generate a systems-level pharmacological effect.
- Data mining strategies were employed to identify predictive attributes within these responses.
Main Results:
- The Pattern Array framework enables screening of novel chemical entities.
- This systems-level approach may enhance the identification of compounds with psychiatric utility.
- The method complements traditional, labor-intensive models.
Conclusions:
- Large-scale, systems-level screening of small molecules can improve psychiatric drug discovery.
- This approach offers a complementary strategy to construct validity models.
- Interdisciplinary collaboration is essential to overcome treatment barriers in psychiatric illness.
Related Concept Videos
Drug Discovery: Overview
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Antidepressant Drugs: MAOIs and Other Agents
Pharmacogenomics: Identification of New Drug Targets

